Helgeland L - Search Results

1

EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.

Berg J, Fjellbirkeland L, Suhrke P, Jebsen P, Lund-Iversen M, Kleinberg L, Helgeland L, Brustugun OT, Helland Å. Berg J, et al. Among authors: helgeland l. Acta Oncol. 2016;55(2):149-55. doi: 10.3109/0284186X.2015.1062537. Epub 2015 Aug 26. Acta Oncol. 2016. PMID: 26313507

2

Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.

Larsen A, Bjørge B, Klementsen B, Helgeland L, Wentzel-Larsen T, Fagerhol MK, Hovdenak N, Dahl O. Larsen A, et al. Among authors: helgeland l. Acta Oncol. 2007;46(5):639-50. doi: 10.1080/02841860601099241. Acta Oncol. 2007. PMID: 17562440

3

[Mutation testing for non-small-cell lung cancer].

Brustugun OT, Helland Å, Fjellbirkeland L, Kleinberg L, Ariansen S, Jebsen P, Scott H, Dønnem T, Bremnes R, Berg T, Grønberg BH, Dai HY, Wahl SG, Mangseth K, Helgeland L. Brustugun OT, et al. Among authors: helgeland l. Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):952-5. doi: 10.4045/tidsskr.11.1017. Tidsskr Nor Laegeforen. 2012. PMID: 22562326 Free article. Norwegian.

4

Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.

Donnem T, Kilvaer TK, Andersen S, Richardsen E, Paulsen EE, Hald SM, Al-Saad S, Brustugun OT, Helland A, Lund-Iversen M, Solberg S, Gronberg BH, Wahl SG, Helgeland L, Fløtten O, Pohl M, Al-Shibli K, Sandanger TM, Pezzella F, Busund LT, Bremnes RM. Donnem T, et al. Among authors: helgeland l. Ann Oncol. 2016 Feb;27(2):225-32. doi: 10.1093/annonc/mdv560. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578726 Free article. Review.

5

Vascular invasion is an adverse prognostic factor in resected non-small-cell lung cancer.

Ramnefjell M, Aamelfot C, Helgeland L, Akslen LA. Ramnefjell M, et al. Among authors: helgeland l. APMIS. 2017 Mar;125(3):197-206. doi: 10.1111/apm.12652. APMIS. 2017. PMID: 28233448

6

Detection of clonality in follicular lymphoma using formalin-fixed, paraffin-embedded tissue samples and BIOMED-2 immunoglobulin primers.

Berget E, Helgeland L, Molven A, Vintermyr OK. Berget E, et al. Among authors: helgeland l. J Clin Pathol. 2011 Jan;64(1):37-41. doi: 10.1136/jcp.2010.081109. Epub 2010 Oct 28. J Clin Pathol. 2011. PMID: 21030528

7

Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas.

Ramnefjell M, Aamelfot C, Helgeland L, Akslen LA. Ramnefjell M, et al. Among authors: helgeland l. Oncotarget. 2017 Oct 3;8(53):90706-90718. doi: 10.18632/oncotarget.21456. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207598 Free PMC article.

8

Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.

Thunestvedt LMØ, Helgeland L, Bachmann IM, Karlsdottir Å, Haslerud TM, Reikvam H. Thunestvedt LMØ, et al. Among authors: helgeland l. Curr Oncol. 2022 Mar 23;29(4):2193-2198. doi: 10.3390/curroncol29040178. Curr Oncol. 2022. PMID: 35448152 Free PMC article.

9

Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy.

Berget E, Helgeland L, Lehmann AK, Smievoll AI, Vintermyr OK, Mørk SJ. Berget E, et al. Among authors: helgeland l. Acta Oncol. 2013 Jun;52(5):1047-9. doi: 10.3109/0284186X.2012.731526. Epub 2012 Oct 16. Acta Oncol. 2013. PMID: 23072723 No abstract available.

10

Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.

Mangseth K, Helgeland L, Klos J, Molven A, Vintermyr OK. Mangseth K, et al. Among authors: helgeland l. Diagn Mol Pathol. 2009 Sep;18(3):150-5. doi: 10.1097/PDM.0b013e31818935d2. Diagn Mol Pathol. 2009. PMID: 19704260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page